These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7371194)

  • 41. Self-mutilation in a patient with mucolipidosis III.
    Zammarchi E; Savelli A; Donati MA; Pasquini E
    Pediatr Neurol; 1994 Jul; 11(1):68-70. PubMed ID: 7986298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enzymatic phosphorylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell fibroblasts.
    Hasilik A; Waheed A; von Figura K
    Biochem Biophys Res Commun; 1981 Feb; 98(3):761-7. PubMed ID: 6452876
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of (+) --cyanidanol on lysosomal enzymes of I-cell fibroblasts.
    Tavella D; Donnelly PV; Di Ferrante N
    Tex Rep Biol Med; 1976; 34(2-4):307-14. PubMed ID: 20673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification and comparison of the structures of human liver acidic alpha-D-mannosidases A and B.
    Cheng SH; Malcolm S; Pemble S; Winchester B
    Biochem J; 1986 Jan; 233(1):65-72. PubMed ID: 3954735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular forms of beta-hexosaminidase and cathepsin D in serum and urine of healthy subjects and patients with elevated activity of lysosomal enzymes.
    Zühlsdorf M; Imort M; Hasilik A; von Figura K
    Biochem J; 1983 Sep; 213(3):733-40. PubMed ID: 6225425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme biosynthesis.
    Mueller OT; Honey NK; Little LE; Miller AL; Shows TB
    J Clin Invest; 1983 Sep; 72(3):1016-23. PubMed ID: 6309902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Light and heavy lysosomes: characterization of N-acetyl-beta-D-hexosaminidase isolated from normal and I-cell disease lymphoblasts.
    Miller AL; Norton V; Robertson R; Jenks M; Yeh RY; Wright D
    Glycobiology; 1993 Aug; 3(4):313-8. PubMed ID: 8400547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The mucolipidoses: identification by abnormal electrophoretic patterns of lysosomal hydrolases.
    Honey NK; Miller AL; Shows TB
    Am J Med Genet; 1981; 9(3):239-53. PubMed ID: 7282783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prenatal diagnosis of mucolipidosis type II on first-trimester amniotic fluid.
    Poenaru L; Mezard C; Akli S; Oury JF; Dumez Y; Boue J
    Prenat Diagn; 1990 Apr; 10(4):231-5. PubMed ID: 1973293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycosidases in human skin fibroblast cultures. Alpha-fucosidase, alpha-galactosidase, alpha-glucosidase, beta-mannosidase, and N-acetyl-alpha-glucosaminidase.
    Hultberg B; Sjöblad S; Ockerman PA
    Acta Paediatr Scand; 1975 Jan; 64(1):123-31. PubMed ID: 234663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lysosomal phospholipase activity is decreased in mucolipidosis II and III fibroblasts.
    Jansen SM; Groener JE; Poorthuis BJ
    Biochim Biophys Acta; 1999 Jan; 1436(3):363-9. PubMed ID: 9989267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. beta-hexosaminidase, alpha-D-mannosidase, and beta-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I.
    Beccari T; Mancuso F; Costanzi E; Tassi C; Barone R; Fiumara A; Orlacchio A; Aisa MC; Orlacchio A
    Clin Chim Acta; 2000 Dec; 302(1-2):125-32. PubMed ID: 11074069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular analysis of cell lines from patients with mucolipidosis II and mucolipidosis III.
    Zarghooni M; Dittakavi SS
    Am J Med Genet A; 2009 Dec; 149A(12):2753-61. PubMed ID: 19938078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Properties and prenatal ontogeny of beta-D-mannosidase in selected goat tissues.
    Pearce RD; Callahan JW; Little PB; Armstrong DT; Kiehm D; Clarke JT
    Biochem J; 1987 Apr; 243(2):603-9. PubMed ID: 3632638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lysosomal hydrolases in macrophages exposed to swainsonine.
    Greenaway VA; Jessup W; Dean RT; Dorling PR
    Biochim Biophys Acta; 1983 Jul; 762(4):569-76. PubMed ID: 6223666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical variability in mucolipidosis III (pseudo-Hurler polydystrophy).
    Tylki-Szymańska A; Czartoryska B; Groener JE; Ługowska A
    Am J Med Genet; 2002 Mar; 108(3):214-8. PubMed ID: 11891688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Juvenile Sandhoff disease: some properties of the residual hexosaminidase in cultured fibroblasts.
    Wood S; MacDougall BG
    Am J Hum Genet; 1976 Sep; 28(5):489-95. PubMed ID: 10724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mucolipidosis type III. Multiple elevated serum and urine enzyme activities.
    Herd JK; Dvorak AD; Wiltse HE; Eisen JD; Kress BC; Miller AL
    Am J Dis Child; 1978 Dec; 132(12):1181-6. PubMed ID: 152578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new variant mucolipidosis: biochemical investigations on two siblings.
    Sandman R; Yatsiv S; Robertson WV; Erickson RP
    Clin Chim Acta; 1977 Nov; 80(3):471-81. PubMed ID: 410566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis of I-cell disease.
    Hwu WL; Chuang SC; Wang WC; Wang TR
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(6):508-13. PubMed ID: 7831983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.